Plasbumin Solution
Product Images NDC 13533-690

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasbumin (NDC 13533-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cartonlabel

Cartonlabel
This is a package insert for Plasbumin-5, a sterile solution used for intravenous infusion. It contains 25g of human albumin in 50 mL of aqueous solution. The product is stabilized with 0.004 M sodium caprylate and 0.004 M acetyltryptophan. It is not recommended to use this product if it appears turbid, and administration should not begin more than 4 hours after entering the container. The patient and physician should discuss the risks and benefits of this product. The package insert contains more information on dosage and administration. The product is manufactured by Grifols Therapeutics LLC and should be stored at room temperature, not exceeding 30°C. The aluminum content should not exceed 200 µg/L, and it contains no preservatives.*
FDA Label Image

Viallabel

Viallabel
This is a description of a medication, specifically albumin (Human) 25% USP, used for intravenous infusion. The text provides instructions for use, including not using the medication if it is turbid and waiting at least four hours after the container has been entered before beginning administration. The text also advises that the patient and physician should discuss the risks and benefits of the product. The medication contains 25g of human albumin and is osmotically equivalent to 50mL of plasma. The medication does not contain a preservative, and any unused portions must be discarded. The manufacturer is Grifols Therapeutics LLC, and dosage and administration instructions are available in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.